Back
Charles River Laboratories International Vs. Biomarin Pharmaceutical Industry Stock Comparison
Sell
43
CRL
Charles River Laboratories International
Last Price:
195.80
Seasonality Move:
9.91%
Buy
61
BMRN
Biomarin Pharmaceutical
Last Price:
64.25
Seasonality Move:
12.47%
Sell
43
Charles River Laboratories International (CRL)
is a Sell
Is Charles River Laboratories International a Buy, Sell or Hold?
- The current Charles River Laboratories International [CRL] share price is $195.77. The Score for CRL is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- CRL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
61
Biomarin Pharmaceutical (BMRN)
is a Buy
Is Biomarin Pharmaceutical a Buy, Sell or Hold?
- The current Biomarin Pharmaceutical [BMRN] share price is $64.26. The Score for BMRN is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- BMRN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CRL Stock Price Chart
What is Charles River Laboratories International's stock price today?
-
The Charles River Laboratories International share price today is $195.77
The current trend is relatively stagnant and CRL is experiencing slight buying pressure.
BMRN Stock Price Chart
What is Biomarin Pharmaceutical's stock price today?
-
The Biomarin Pharmaceutical share price today is $64.26
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing slight buying pressure.
CRL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.08 | Sell |
Relative Strength Index (14 RSI): | 50.6 | Buy |
Chaikin Money Flow: | 11698 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (180.82 - 205.92) | Buy |
Bollinger Bands (100): | (187.27 - 217.23) | Sell |
BMRN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.96 | Sell |
Relative Strength Index (14 RSI): | 38.59 | Sell |
Chaikin Money Flow: | 518116 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (63.94 - 69.24) | Sell |
Bollinger Bands (100): | (67.93 - 87.19) | Sell |
CRL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 192.83 | Buy |
20-day SMA: | 195.09 | Buy |
50-day SMA: | 195.01 | Buy |
200-day SMA: | 219.12 | Sell |
8-day EMA: | 194.21 | Buy |
20-day EMA: | 195.09 | Buy |
50-day EMA: | 196.22 | Sell |
200-day EMA: | 208.31 | Sell |
BMRN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 63.73 | Buy |
20-day SMA: | 65.69 | Sell |
50-day SMA: | 68.56 | Sell |
200-day SMA: | 81.05 | Sell |
8-day EMA: | 63.9 | Buy |
20-day EMA: | 65.57 | Sell |
50-day EMA: | 69.74 | Sell |
200-day EMA: | 79.39 | Sell |
Charles River Laboratories International Earnings Growth & CRL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.42 per share, and an increase next year of $0.13 per share.
Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.23 per share, and an increase next year of $0.83 per share.
Charles River Laboratories International Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Biomarin Pharmaceutical Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |